Cargando…
Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis
BACKGROUND: Previous meta-analyses of treatments for pulmonary arterial hypertension (PAH) have not shown mortality benefit from any individual class of medication. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from inception through November 2009 for...
Autores principales: | Ryerson, Christopher J, Nayar, Shalini, Swiston, John R, Sin, Don D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835653/ https://www.ncbi.nlm.nih.gov/pubmed/20113497 http://dx.doi.org/10.1186/1465-9921-11-12 |
Ejemplares similares
-
Pharmacotherapy for pulmonary arterial hypertension
por: Burki, Talha Khan
Publicado: (2020) -
A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy
por: Ataya, Ali, et al.
Publicado: (2016) -
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension
por: Idrees, Majdy M., et al.
Publicado: (2014) -
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: General management for pulmonary hypertension
por: Idrees, Majdy M., et al.
Publicado: (2014) -
Management Considerations for Pulmonary Arterial Hypertension Pharmacotherapy in the Intensive Care Unit
por: Foster, Elizabeth M., et al.
Publicado: (2023)